ARTICLE | Clinical News

DAB389IL-2 fusion toxin data

December 13, 1993 8:00 AM UTC

Further interim analysis of this Phase I trial showed one complete remission each in the 14 patients with CTCL and the 11 patients with NHL evaluable so far. Five of the CTCL group and two of the NHL ...